described extensively elsewhere.' 2 There are several situations under which cell death may occur in bone as a physiological event (table 1) . Probably the best recognised of these is during ossification of the growth plate. Hypertrophic chondrocytes disappear as growth plate cartilage calcifies and is resorbed from the primary spongiosa. Recent evidence has suggested that hypertrophic chondrocytes undergo apoptosis at this site.' As the balance of evidence suggests that osteoclasts usually disappear at the cessation of their resorptive activity, it would seem likely that they undergo some form of cell death. In addition, it is conceivable that regulation of numbers of osteoclast precursors through induction of cell death may represent a mechanism by which the number of mature osteoclasts at any site is controlled. Whether cell death is an important event in the control of the activity of the osteoblast lineage is more difficult to gauge. From a theoretical perspective, it is possible that the number of mature osteoblasts that form in any BMU depends upon the balance of mitosis and apoptosis of their marrow stroma derived precursors. Also, although there are two well defined fates for osteoblasts (differentiation into osteocytes or lining cells), it is also possible that some osteoblasts undergo cell death.The remainder of this article provides an overview of what is currently known about cell death in the osteoclast and osteoblast lineages, and how the death of these cells may be of relevance to clinically important bone diseases.
Cell death: general considerations Cell death is a surprisingly complex process that has received much study during the 1 990s, having being all but ignored during the previous century. In simple terms, cells can be murdered (necrotic cell death) or commit suicide (apoptotic cell death). The complexities of cell death have been eloqifently reviewed elsewhere,4 and the distinction between necrotic and apoptotic cell death is becoming increasingly familiar to the general scientific audience. Apoptosis represents the "physiological" mode of cell death and is therefore of relevance to the normal cellular events of bone. The important characteristics of apoptosis are:
(1) apoptosis consists of a fairly stereotyped sequence of morphologically recognisable events; (2) apoptosis is controlled from within the cell by a large number of regulatory factors, but can be induced or inhibited by external factors through receptor mediated mechanisms.
Osteoclast apoptosis REGULATION OF OSTEOCLAST ACTIVITY
The osteoclast is a rare and elusive cell. Osteoclasts can be found at any of the million or so active remodelling sites that exist at any one time in the adult human skeleton, but occupy a very small proportion of the total bone surface. The osteoclast is extremely rapid and effective in destroying bone matrix, therefore its activity has to be tightly regulated to maintain normal skeletal homeostasis. The potentially disastrous consequences of loss of regulation of osteoclast activity are all too apparent in lytic bone diseases such as myeloma. The regulation of osteoclast formation and bone resorption has received considerable study (reviewed by Mundy and Roodman6). It is now well known that osteoclasts are derived from haematopoietic precursors that appear to be phenotypically indistinguishable from the precursors of the monocyte/macrophage lineage until a very late stage in their differentiation, at which time they begin to acquire characteristics of adult (multinucleated, bone resorbing) osteoclasts such as expression of tartrate resistant acid phosphatase (TRAP) and calcitonin receptors. The proliferation and differentiation of the precursors is controllable by a wide range of factors including systemic hormones such as parathyroid hormone (PTH), 1,25-dihydroxyvitamin D, (1,25D) and sex steroids, and cytokines/ growth factors such as granulocyte macrophage colony-stimulating factor (GM-CSF), macrophage-colony stimulating factor (M-CSF), and interleukin (IL)-6. Mature osteoclasts are thought to lack receptors for most of the factors capable of stimulating or inhibiting In these mice, SV40 T antigen was under the control of the TRAP promoter, resulting in abnormal proliferation of osteoclasts and their precursors. Rather than developing osteoporosis, as might be expected because of the increased numbers of osteoclasts, these animals developed osteopetrosis (increased bone density). Unexpectedly, many osteoclasts showed the morphological features of apoptosis, an observation that was supported by a DNA strand end-labelling technique designed to detect the ends of DNA fragments resulting from the endonuclease activity characteristic of apoptosis." '' These observations indicated that increases in osteoclast apoptosis may reduce bone resorption (hence the development of osteopetrosis in these mice) and raised the question of whether apoptosis might be a physiological event in the life cycle of the osteoclast. The question of the fate of normal osteoclasts was addressed by histological examination of calvarial bones from mice treated with local injections of recombinant IL-1. In this model, IL-1 causes intense, localised bone resorption that is followed by abrupt cessation of resorption and new bone formation several days after the cessation of IL-1
injections."' Histological examination of bones taken on the fourth day after the last IL-1 injection revealed a very high proportion (up to 13%) of osteoclasts showing the morphological features of apoptosis, namely loss of adhesion to the bone surface, cytoplasmic contraction and blebbing, nuclear chromatin condensation, and nuclear fragmentation.'6 The osteo-
clasts showing these characteristics were very rarely situated at active resorption fronts, usually being at sites of reversal between areas of active resorption and active bone formation. These observations strongly suggest that apoptosis is the normal fate of osteoclasts at reversal, and have subsequently been supported by a study in which the calcium repletion model of Liu and co-workers'0 was revisited to show that the rapid loss of osteoclasts from the bone surface in these animals was associated with apoptosis. '7 REGULATION OF OSTEOCLAST APOPTOSIS Methods used to study osteoclast apoptosis The study of osteoclast apoptosis has been complicated by the comparative rarity of this cell type and the short duration of morphologically recognisable apoptosis. It is also difficult to isolate large numbers of osteoclasts in vitro and it is impossible to achieve a 100% pure population of these cells. However, a characteristic feature of the osteoclast is that it continues to express TRAP strongly during apoptosis (fig lb and c 
